The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.00377-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Aaron C Nolan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, School of Biological and Chemical Sciences and Institute for Health Discovery and Innovation, University of Galway, Galway, Ireland. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Guanosine, Anti-Bacterial Agents, Thymidine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, Joint Programming Initiative on Antimicrobial Resistance, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Efforts to improve the effectiveness of existing interventions for antimicrobial-resistant infections include identifying new ways to overcome resistance to licensed antibiotics using adjuvants or deploying antibiotics in novel combinations. Although antibiotics targeting the bacterial cell wall (e.g., β-lactams) and folate metabolism (e.g., trimethoprim-sulfamethoxazole [TMP-SMX]) remain cornerstones of modern healthcare, resistance to both classes poses an ongoing therapeutic challenge. We recently demonstrated that purine nucleosides can act as potent antibiotic adjuvants, restoring β-lactam susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Here, we show that guanosine significantly reduces intracellular thymidine levels in MRSA and potentiates the activity of antifolate antibiotics (TMP-SMX), as well as the pyrimidine antimetabolites 5-fluorouracil and 5-fluorouridine. Incorporation of oxacillin into guanosine-antifolate or guanosine-pyrimidine analog combinations further enhanced killing of both planktonic and biofilm-associated MRSA. Thymidine depletion was accompanied by elevated intracellular reactive oxygen species and dissipation of membrane potential, providing mechanistic insight into the bactericidal effects of these combinations. Together, these findings demonstrate that guanosine expands MRSA susceptibility beyond β-lactams to include additional clinically relevant antimicrobial drug classes commonly used to treat bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology, School of Biological and Chemical Sciences and Institute for Health Discovery and Innovation, University of Galway, Galway, Ireland.
- Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Aaron C Nolan, Jessica B Kelly, Vinai C Thomas, Merve S Zeden, James P O'Gara
Förderung
- Science Foundation Ireland
- Joint Programming Initiative on Antimicrobial Resistance
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Nolan, A. C., Kelly, J. B., Ahn, J., Shinde, D., Thomas, V. C., Zeden, M. S., & O'Gara, J. P. (2026). The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00377-26
Vancouver
Nolan AC, Kelly JB, Ahn J, Shinde D, Thomas VC, Zeden MS, et al. The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00377-26
BibTeX
@article{Nolan2026,
author = {Nolan, Aaron C and Kelly, Jessica B and Ahn, Jongsam and Shinde, Dhananjay and Thomas, Vinai C and Zeden, Merve S and O'Gara, James P},
title = {The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00377-26}
}
EUVIMED